Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Drug Safety
Published in: Drug Safety 6/1998

01-06-1998 | Review Article

Drug Administration in Patients with Diabetes Mellitus

Safety Considerations

Authors: Dr Richard E. Gilbert, Mark E. Cooper, Henry Krum

Published in: Drug Safety | Issue 6/1998

Login to get access
Metadata
Title
Drug Administration in Patients with Diabetes Mellitus
Safety Considerations
Authors
Dr Richard E. Gilbert
Mark E. Cooper
Henry Krum
Publication date
01-06-1998
Publisher
Springer International Publishing
Published in
Drug Safety / Issue 6/1998
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-199818060-00005

Other articles of this Issue 6/1998

Drug Safety 6/1998 Go to the issue

Leading Article

Drug-Food Interactions in Hospitalised Patients

Review Article

A Risk-Benefit Assessment of Irinotecan in Solid Tumours

Review Article

Pain Treatment in Multimorbid Patients, the Older Population and Other High-Risk Groups

Review Article

A Risk-Benefit Assessment of Pharmacological Treatments for Panic Disorder

Review Article

Minocycline-Induced Pigmentation